EMA Product Specific GL [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-07-28 14:40 (2456 d 19:56 ago) – Posting: # 17620
Views: 8,464

Dear all,

a new set of product-specific guidances was adopted by CHMP for public consultation on 22 June (published on 28 July [1–4], 3 August [5–7]). Deadline for comments: 31 October.
  1. Dolutegravir film-coated tablets 10 mg, 25 mg and 50 mg
  2. Dronedarone film-coated tablets 400 mg
  3. Paracetamol oral use, immediate release formulations
  4. Rilpivirine film-coated tablets 25 mg
  5. Dimethyl fumarate gastro-resistant capsules 120 mg and 240 mg
  6. Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg
  7. Tadalafil film-coated tablets 2.5 mg, 5 mg, 10 mg and 20 mg

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,663 registered users;
88 visitors (0 registered, 88 guests [including 7 identified bots]).
Forum time: 10:36 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5